Board to consider Q1 results and interim dividend on 30 July

Corporate Actions View source PDF Explain this filing

AJANTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.7%Reaction day

₹3410.00

prior close

₹3447.70

announcement price

In-mkt

timing

Nifty Midcap 150market+0.5%+1.1% vs market

Pharmaceuticals peers, median of 167sector+0.8%+0.9% vs sector

On the reaction day the stock moved 1.1 pts more than Nifty Midcap 150 and 0.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+0.2

15m

+0.3

30m

+0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.7+0.5+1.1+0.8+0.9

Next day

+4.8+0.9+4.0+0.8+4.1

+1.2-0.2+1.4-0.6+1.8

+0.6-1.1+1.8-1.7+2.4

-1.1-1.2+0.1-1.6+0.4

-0.7-0.2-0.5-0.7+0.0

-0.0+0.7-0.7-0.9+0.9

15d

+2.9+2.2+0.7+0.6+2.3

+8.2+1.8+6.4-1.1+9.3

+3.6-0.7+4.3+1.8+1.8

-4.4-7.7+3.3-4.6+0.2

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ajanta Pharma has informed BSE that its Board meeting on 30 July 2026 will consider unaudited Q1 FY27 financial results (quarter ended 30 June 2026) and declaration of the 1st interim dividend for FY ending 31 March 2027. Record date fixed as Wednesday, 5 August 2026 for the interim dividend, if declared.

Likely market impact

Positive signal for income investors. Dividend amount and stock reaction will depend on what the Board actually declares on 30 July.